Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06444360 · ClinicalTrials.gov registry record · NA
Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
A NA study of HIV, sponsored by Westat.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 2
- Study locations
NCT06444360: Recruiting NA study of HIV, sponsored by Westat.
NCT06444360 is a NA study of HIV that is actively recruiting participants, run by Westat. The registered enrollment target is 360 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (18% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06444360, a NA study of HIV, is actively recruiting participants, sponsored by Westat.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 2
- Study locations
Study Summary
The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.
Primary Outcome
The number of times participants report engaging in condomless sex without the protection of PrEP (for those not living with HIV) or viral suppression (for those living with HIV).
Conditions Studied
Interventions
- BEHAVIORAL IMPACT
- BEHAVIORAL eSOC
Study Locations (2)
California
- University of California, Los Angeles - Los Angeles
Rhode Island
- Brown University - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2025-11-04 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
What NCT06444360 shows while recruiting
NCT06444360 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (18% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which IMPACT is the first listed.
NCT06444360 reports a single indexed study location in California, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06444360 about?
NCT06444360 is a clinical study titled "Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults". The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.
What is the current status of trial NCT06444360?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2025-11-04. Estimated completion is 2028-07-31.
What conditions does trial NCT06444360 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT06444360?
The interventions under investigation include: IMPACT (BEHAVIORAL), eSOC (BEHAVIORAL).
Who is sponsoring clinical trial NCT06444360?
This trial is sponsored by Westat, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06444360 being conducted?
This trial has 2 study locations across California, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06444360's enrollment target sits among peer trials
360 54th of 303 higher than 248 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI